Atai Capital returned 3.1% in the fourth quarter, bringing our full-year 2024 returns to 7.7% net of all fees. Click here to ...
The NIH says funding cuts would save it billions of dollars a year. D.C.-area industry and academic leaders say it would cripple R&D.
Find out about what's behind the increase of securities class action lawsuits in the biotech industry and how to prevent them ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback